CRP and hepatocellular carcinoma: The C-reactive protein albumin (CRP/Alb) ratio, a novel inflammation-based prognostic score, has been demonstrated to show outstanding prognostic value in hepatocellular carcinoma compared with other established inflammation-based prognostic scores [14].